Third Harmonic Bio Q3 EPS $(0.61) Misses $(0.27) Estimate
Portfolio Pulse from Benzinga Newsdesk
Third Harmonic Bio (NASDAQ:THRD) reported Q3 losses of $(0.61) per share, missing the analyst consensus estimate of $(0.27) by 125.93%. This is a 32.22% increase over losses of $(0.90) per share from the same period last year.
November 09, 2023 | 1:33 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Third Harmonic Bio's Q3 earnings missed analyst estimates by a significant margin, which could negatively impact the stock price in the short term.
Third Harmonic Bio reported a larger than expected loss for Q3, missing analyst estimates by 125.93%. This negative earnings surprise could lead to a decrease in the stock price as it indicates the company's performance was worse than expected.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100